Tuesday, 29 April 2014

FDA: Drugs Approved in February: NDA Drugs



"Drug Name and FDA Appl. #" Active Ingredients Company Approval Date
IMBRUVICA (NDA #205552) IBRUTINIB PHARMACYCLICS INC 2/12/2014
VIMIZIM (BLA #125460) ELOSULFASE ALFA BIOMARIN PHARM 2/14/2014
NORTHERA (NDA #203202) DROXIDOPA CHELSEA THERAPS INC 2/18/2014
MYALEPT (BLA #125390) METRELEPTIN AMYLIN PHARMS LLC 2/24/2014
TIVORBEX (NDA #204768) INDOMETHACIN IROKO PHARMS LLC 2/24/2014



Source: FDA

0 comments:

Post a Comment